Brought to you by 
OpGen nets $18mm in IPO
15 Jul 2015
Executive Summary
OpGen Inc. netted $18mm through its initial public offering of 3.27mm units (including the overallotment) at $6. Each unit consists one common share of common stock and a five-year warrant to purchase one share at an exercise price of $6.60. The company first announced plans to sell 3.75mm shares between $8 and $10 each, and shortly thereafter said it would offer 2.5mm units at $5.50-6.50.
Deal Industry
- In Vitro Diagnostics
- Research, Analytical Equipment & Supplies
- Services
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
-
Biotechnology
-
Drug Discovery Tools
- Bioinformatics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
OpGen nets $18mm in IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice